Li Yu

Title: Li Yu: Biomedical and Vaccine Innovation in Kunming

Introduction

Li Yu is an inventor based in Kunming, China, whose work focuses on biomedical research and vaccine technologies. His patent portfolio includes 2 patents addressing enterovirus strains and vaccine development.

Latest Patents

- Coxsackievirus A6 strain CVA6-KM-J33 and use thereof. This invention describes a Coxsackievirus A6 strain that is susceptible to KMB17 cells and can achieve a relatively high titer. The strain’s virulence, pathogenicity, and immunogenicity make it a candidate for CVA6 vaccine development. It may also support vaccine immunogenicity and protection evaluations, as well as the preparation of animal models for Coxsackievirus infection.

- Enterovirus multi-antigen epitope fusion protein, gene, vaccine, and preparation method thereof. This invention presents a fusion protein and related gene and vaccine technology for vaccine preparation. Its genetically engineered protein approach is intended to produce a vaccine with greater specificity, fewer impurity proteins after purification, and a higher proportion of specific antigen proteins, supporting the effectiveness and safety of combined vaccines.

Career Highlights

Li Yu’s listed professional affiliations include the Chinese Academy of Medical Sciences and its Institute of Medical Biology. His patent work connects biomedical research with practical applications in vaccine evaluation, vaccine preparation, and infectious-disease modeling.

Collaborations

Li Yu’s listed coworkers include Longding Liu and Heng Li. Their shared research context includes work related to biomedical and vaccine technologies.

Conclusion

Li Yu’s inventions contribute to CVA6 vaccine research and enterovirus vaccine development, with applications in evaluation, preparation, and disease modeling.